ImmunityBio, Inc 10-K for FY2022
ImmunityBio, Inc. (IBRX)
10-K
2023-03-01
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
ImmunityBio, Inc filed this 10-K on March 1, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $240K
- down 74.3% from $934K a year earlier
- Net loss
- $416.57M
- compared with a net loss of $346.79M a year earlier
- Diluted EPS
- -$1.04
- compared with -$0.89 a year earlier